Free Trial

Centene (CNC) Stock Forecast & Price Target

Centene logo
$74.29 +3.02 (+4.24%)
As of 01:50 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Centene - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
1
Hold
11
Buy
9

Based on 21 Wall Street analysts who have issued ratings for Centene in the last 12 months, the stock has a consensus rating of "Hold." Out of the 21 analysts, 1 has given a sell rating, 11 have given a hold rating, and 9 have given a buy rating for CNC.

Consensus Price Target

$73.80
-0.66% Downside
According to the 21 analysts' twelve-month price targets for Centene, the average price target is $73.80. The highest price target for CNC is $82.00, while the lowest price target for CNC is $40.00. The average price target represents a forecasted downside of -0.66% from the current price of $74.29.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CNC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Centene and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNC Analyst Ratings Over Time

TypeCurrent Forecast
11/16/25 to 11/16/26
1 Month Ago
10/17/25 to 10/17/26
3 Months Ago
8/18/25 to 8/18/26
1 Year Ago
11/16/24 to 11/16/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
9 Buy rating(s)
8 Buy rating(s)
3 Buy rating(s)
Hold
11 Hold rating(s)
10 Hold rating(s)
9 Hold rating(s)
14 Hold rating(s)
Sell
1 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
3 Sell rating(s)
Consensus Price Target$73.80$70.05$69.15$39.47
Forecasted Upside-0.66% Downside1.12% Upside5.92% Upside8.44% Upside
Consensus RatingHoldHoldHoldHold

CNC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CNC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Centene Stock vs. The Competition

TypeCenteneHealthcare CompaniesBroader Market
Consensus Rating Score
2.38
2.32
2.52
Consensus RatingHoldHoldModerate Buy
Predicted Upside-1.41% Downside116.80% Upside15.45% Upside
News Sentiment Rating
Positive News

See Recent CNC News
Positive News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
11/2/2026
Truist Financial Corporation logo
Truist Financial
2 of 5 stars
David MacDonald
3 of 5 stars
Reiterated RatingBuy$80.00 ➝ $82.00+25.46%
10/30/2026
Stephen Baxter
Stephen Baxter
4 of 5 stars
Boost TargetEqual Weight$69.00 ➝ $75.00+11.88%
10/29/2026
David Windley
David Windley
Not Rated
Reiterated RatingHold$69.00+2.81%
10/29/2026Boost TargetNeutral$67.00 ➝ $75.00+9.86%
10/28/2026 UpgradeSell (D+) ➝ Hold (C-)
10/28/2026Set Target$79.00+15.10%
10/28/2026Set TargetEqual Weight$66.00 ➝ $71.00+3.13%
10/28/2026Set Target$72.00+6.34%
10/28/2026Reiterated RatingBuy$80.00 ➝ $82.00+19.21%
10/28/2026Boost TargetNeutral$70.00 ➝ $78.00+16.22%
10/28/2026Boost TargetOverweight$80.00 ➝ $82.00+19.27%
10/28/2026Boost TargetOverweight$75.00 ➝ $79.00+14.85%
10/28/2026Boost TargetNeutral$66.00 ➝ $71.00+3.22%
10/5/2026 DowngradeStrong-Buy ➝ Hold
9/11/2026 Reiterated RatingBuy
8/11/2026UpgradeHold ➝ Buy$80.00+20.28%
8/3/2026 Set Target$79.00+26.95%
8/3/2026Reiterated RatingOutperform$68.00 ➝ $79.00+26.95%
7/14/2026Reiterated RatingHold$47.00 ➝ $65.00-5.62%
7/9/2026Boost TargetSector Perform$70.00 ➝ $71.00+6.05%
5/27/2026Boost TargetOutperform$58.00 ➝ $67.00+12.22%
5/20/2026UpgradeHold ➝ Buy$53.00 ➝ $80.00+35.20%
4/29/2026 Reiterated RatingSell$40.00-19.07%
4/29/2025Reiterated RatingNeutral
12/13/2024 Lower TargetEqual Weight$75.00 ➝ $73.00+22.09%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:51 PM ET.


Should I Buy Centene Stock? CNC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, November 12, 2026. Please send any questions or comments about these Centene pros and cons to contact@marketbeat.com.

Centene
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Centene Co.:

  • Centene Co. recently reported strong third-quarter results, beating analyst expectations with earnings per share of $0.58 compared to a consensus estimate of $0.10, while also exceeding revenue forecasts with $50.65 billion in sales against an expected $47.12 billion.
  • The company has raised its full-year 2026 adjusted earnings per share guidance to above $5.20, signaling confidence in its financial trajectory, and achieved a breakeven forecast for its Medicare Advantage segment one year earlier than originally planned.
  • Centene Co. shares are currently trading at $70.38, a significant increase from its 52-week low of $31.63, reflecting a strong upward trend and recent momentum as the stock hit a fresh 52-week high in early November 2026.
  • Analyst sentiment has improved recently, with the consensus price target rising to $73.80, and several firms including Bank of America and JPMorgan Chase raising their individual price targets in late October 2026, indicating growing institutional confidence.
  • Institutional interest remains robust, with major investors like BlackRock and Wellington Management Group significantly increasing or establishing new positions in the company during the second quarter, suggesting long-term capital commitment to the managed healthcare sector.

Centene
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Centene Co. for these reasons:

  • Despite the recent price rally, the overall consensus rating from research analysts remains a "Hold," with eleven analysts issuing Hold ratings compared to nine Buy ratings, suggesting that many experts believe the stock is fairly valued or lacks significant upside potential at current levels.
  • Unusual options trading activity was observed in early November 2026, with a 165% increase in put option volume compared to typical daily averages, which may indicate that some market participants are hedging against potential downside risk or expecting volatility.
  • Short interest in Centene Co. remains notable, with over 10.5 million shares shorted as of late October 2026, representing a short percentage of float that, while modest, indicates a segment of the market is betting against the stock's performance.
  • Insider selling activity has been present, with the General Counsel selling a total of over 100,000 shares in August 2026, which some investors may interpret as a lack of confidence from company leadership at current price levels.
  • The company operates in a highly regulated government-sponsored healthcare environment, and recent political shifts, such as the change in congressional control, could introduce policy uncertainties that may impact reimbursement rates and operational costs for Medicaid and Medicare programs.

CNC Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Centene is $73.80, with a high forecast of $82.00 and a low forecast of $40.00.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last twelve months. There is currently 1 sell rating, 11 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CNC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CNC, but not buy additional shares or sell existing shares.

According to analysts, Centene's stock has a predicted downside of -0.66% based on their 12-month stock forecasts.

Over the previous 90 days, Centene's stock had 2 upgrades and 1 downgrade by analysts.

Analysts like Centene more than other "healthcare" companies. The consensus rating score for Centene is 2.38 while the average consensus rating score for "healthcare" companies is 2.32. Learn more on how CNC compares to other companies.


MarketBeat monitors more than a dozen sources for Centene analyst ratings, with the most recent rating issued on 11/2/2026.
From Our Partners